Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C
Reproductive Medicine Unit, University of Bologna, Italy.
J Clin Endocrinol Metab. 1988 Feb;66(2):327-33. doi: 10.1210/jcem-66-2-327.
Pulsatile GnRH administration consistently restores normal reproductive hormone levels and ovulation in women with hypogonadotropic hypogonadism, but is less effective in those with polycystic ovarian disease (PCOD). We pharmacologically created a hypogonadotropic condition with a GnRH analog (GnRH-A) in six women with PCOD to investigate the role of deranged gonadotropin secretion in PCOD and to improve the response to pulsatile GnRH ovulation induction. Before GnRH and GnRH-A treatment the women with PCOD had increased LH pulse frequency [one pulse every 55 +/- 2 (+/- SE) min; P less than 0.05] and LH pulse amplitude (10.9 +/- 1.4 U/L; P less than 0.05) compared to normal women in the follicular phase of their menstrual cycle. Each PCOD woman completed one cycle of pulsatile GnRH administration for ovulation induction before (pre-A cycles; n = 6) and one or two cycles after (post-A cycles; n = 9) GnRH-A administration [D-Ser(tBu)6-Des,Gly10-GnRH; 300 micrograms, sc, twice daily for 8 weeks]. Pulsatile GnRH (5 micrograms/bolus) was given at 60-min intervals using a Zyklomat pump. Daily blood samples were drawn during the pulsatile GnRH ovulation induction cycles for the determination of serum LH, FSH, estradiol (E2), progesterone, and testosterone, and pelvic ultrasonography was done at 1- to 4-day intervals. Mean (+/- SE) serum LH levels were elevated during the pre-A cycle (49.2 +/- 3.1 IU/L) and decreased to normal levels during the post-A cycles (19.6 +/- 1.4 IU/L; P less than 0.0001). Mean testosterone concentrations were lower during the post-A cycles [88 +/- 2 ng/dL (3.1 +/- 0.1 nmol/L)] than during the pre-A cycles [122 +/- 3 ng/dL (4.2 +/- 0.1 nmol/L); P less than 0.0001]. In the follicular phase of the post-A cycles E2 levels were significantly lower [81 +/- 5 pg/mL (300 +/- 20 pmol/L) vs. 133 +/- 14 pg/mL (490 +/- 50 pmol/L); P less than 0.0001], preovulatory ovarian volume was smaller (24.6 +/- 2.0 vs. 31.4 +/- 2.4 cm3; P less than 0.01), and the FSH to LH ratio was higher (0.56 +/- 0.03 vs. 0.16 +/- 0.01) than in the pre-A cycle, suggesting more appropriate function of the pituitary-gonadal axis. Excessive LH and E2 responses to pulsatile GnRH administration in the early follicular phase of the pre-A cycle were abolished in the post-A cycles.(ABSTRACT TRUNCATED AT 400 WORDS)
脉冲式促性腺激素释放激素(GnRH)给药能持续恢复低促性腺激素性性腺功能减退女性的正常生殖激素水平并诱导排卵,但对多囊卵巢疾病(PCOD)患者的效果较差。我们用GnRH类似物(GnRH-A)对6名PCOD女性进行药物性低促性腺激素处理,以研究紊乱的促性腺激素分泌在PCOD中的作用,并改善对脉冲式GnRH诱导排卵的反应。在GnRH和GnRH-A治疗前,PCOD女性的促黄体生成素(LH)脉冲频率[每55±2(±标准误)分钟1次脉冲;P<0.05]和LH脉冲幅度(10.9±1.4 U/L;P<0.05)高于处于月经周期卵泡期的正常女性。每位PCOD女性在GnRH-A给药前(A周期前;n = 6)完成一个脉冲式GnRH诱导排卵周期,在GnRH-A给药后(A周期后;n = 9)完成一或两个周期[D-丝氨酸(叔丁基)6-去甘氨酸10-GnRH;300微克,皮下注射,每日2次,共8周]。使用Zyklomat泵以60分钟间隔给予脉冲式GnRH(5微克/脉冲)。在脉冲式GnRH诱导排卵周期中每天采集血样以测定血清LH、促卵泡生成素(FSH)、雌二醇(E2)、孕酮和睾酮,并每隔1至4天进行盆腔超声检查。A周期前血清LH平均(±标准误)水平升高(49.2±3.1 IU/L),A周期后降至正常水平(19.6±1.4 IU/L;P<0.0001)。A周期后平均睾酮浓度[88±2 ng/dL(3.1±0.1 nmol/L)]低于A周期前[122±3 ng/dL(4.2±0.1 nmol/L);P<0.0001]。在A周期后的卵泡期,E2水平显著降低[81±5 pg/mL(300±20 pmol/L)对133±14 pg/mL(490±50 pmol/L);P<0.0001],排卵前卵巢体积较小(24.6±2.0对31.4±2.4 cm3;P<0.01),且FSH与LH比值高于A周期前(0.56±0.03对0.16±0.01),提示垂体-性腺轴功能更正常。A周期前卵泡早期对脉冲式GnRH给药的过度LH和E2反应在A周期后消失。(摘要截短于400字)